Marco Alings - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Marco Alings

Showing results (41-50 of 127) with videos related to

Pageof 13

Sort By:

Heart Rhythm|June 14, 2014

Digoxin in patients with permanent atrial fibrillation: data from the RACE II studyBart A Mulder, Dirk J Van Veldhuisen, Harry J G M Crijns, et al.

Heart Rhythm|January 18, 2025

Clinical significance of a new diagnosis of atrial fibrillation in patients with vascular diseaseAlexander P Benz, Marco Alings, Jacqueline Bosch, et al.

Circulation|November 12, 2023

Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA TrialsWilliam F McIntyre, Alexander P Benz, Nina Becher, et al.

European Heart Journal|September 5, 2014

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROESThomas Vanassche, Mandy N Lauw, John W Eikelboom, et al.

Journal of the American Heart Association|February 9, 2018

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TrialTymon Pol, Claes Held, Johan Westerbergh, et al.

International Journal of Cardiology|November 18, 2016

Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trialPatrícia O Guimarães, Daniel M Wojdyla, John H Alexander, et al.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 19, 2014

Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II studyRob A Vermond, Harry J G M Crijns, Jan G P Tijssen, et al.

JACC. Advances|August 12, 2024

Characteristics and Management of Patients With Cancer and Atrial Fibrillation: The BLITZ-AF Cancer RegistryMichele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, et al.

United European Gastroenterology Journal|August 11, 2023

A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH surveyStan Driessen, Vivian D de Jong, Koen C van Son, et al.

Giornale Italiano Di Cardiologia (2006)|April 19, 2024

[BLITZ-AF Cancer study: an international observational research project on patients with atrial fibrillation and cancer]Michele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, et al.

Pageof 13

Search research articles

Showing results (41-50 of 127) with videos related to

Sort By:

Pageof 13

Heart Rhythm|June 14, 2014

Digoxin in patients with permanent atrial fibrillation: data from the RACE II studyBart A Mulder, Dirk J Van Veldhuisen, Harry J G M Crijns, et al.

Heart Rhythm|January 18, 2025

Clinical significance of a new diagnosis of atrial fibrillation in patients with vascular diseaseAlexander P Benz, Marco Alings, Jacqueline Bosch, et al.

Circulation|November 12, 2023

European Heart Journal|September 5, 2014

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROESThomas Vanassche, Mandy N Lauw, John W Eikelboom, et al.

Journal of the American Heart Association|February 9, 2018

International Journal of Cardiology|November 18, 2016

Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II studyRob A Vermond, Harry J G M Crijns, Jan G P Tijssen, et al.

JACC. Advances|August 12, 2024

Characteristics and Management of Patients With Cancer and Atrial Fibrillation: The BLITZ-AF Cancer RegistryMichele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, et al.

United European Gastroenterology Journal|August 11, 2023

A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH surveyStan Driessen, Vivian D de Jong, Koen C van Son, et al.

Giornale Italiano Di Cardiologia (2006)|April 19, 2024

[BLITZ-AF Cancer study: an international observational research project on patients with atrial fibrillation and cancer]Michele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, et al.

Pageof 13